FARMINGDALE, N.Y.--(BUSINESS WIRE)--Sept. 19, 2006--Enzo Biochem, Inc. (NYSE:ENZ) announced today that it has reached a settlement with Sigma-Aldrich Corp. Sigma was the defendant in a suit brought by Enzo alleging, among other things, breach of contract and infringement of patents related to the Company’s proprietary labeled nucleotide technology.
